Evidence map›Paper›PMID 36769243›Full record

ArticleInternational journal of molecular sciences2023

Optimization of the Hemolysis Assay for the Assessment of Cytotoxicity.

Ingvill Pedersen Sæbø, Magnar Bjørås, Henrik Franzyk, Emily Helgesen, James Alexander Booth

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Tryptophan Biosynthesis GeneAnimals : an open access journal from MDPI · 2026
    Article
  18. Article
  19. Article
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ingvill Pedersen SæbøDepartment of Microbiology, Oslo University Hospital, University of Oslo, Rikshospitalet, 0373 Oslo, Norway.
Magnar BjøråsDepartment of Microbiology, Oslo University Hospital, University of Oslo, Rikshospitalet, 0373 Oslo, Norway.ORCID 0000-0001-8759-1170
Henrik FranzykDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.ORCID 0000-0002-2822-1927
Emily HelgesenDepartment of Microbiology, Oslo University Hospital, University of Oslo, Rikshospitalet, 0373 Oslo, Norway.
James Alexander BoothDepartment of Microbiology, Oslo University Hospital, University of Oslo, Rikshospitalet, 0373 Oslo, Norway.

Funding

Norwegian Research Council BIOTEK2021 327005Trond Mohn Foundation TAMiR
6 · The paper itself

Abstract

In vitro determination of hemolytic properties is a common and important method for preliminary evaluation of cytotoxicity of chemicals, drugs, or any blood-contacting medical device or material. The method itself is relatively straightforward, however, protocols used in the literature vary substantially. This leads to significant difficulties both in interpreting and in comparing the obtained values. Here, we examine how the different variables used under different experimental setups may affect the outcome of this assay. We find that certain key parameters affect the hemolysis measurements in a critical manner. The hemolytic effect of compounds tested here varied up to fourfold depending on the species of the blood source. The use of different types of detergents used for generating positive control samples (i.e., 100% hemolysis) produced up to 2.7-fold differences in the calculated hemolysis ratios. Furthermore, we find an expected, but substantial, increase in the number of hemolyzed erythrocytes with increasing erythrocyte concentration and with prolonged incubation time, which in turn affects the calculated hemolysis ratios. Based on our findings we propose an optimized protocol in an attempt to standardize future hemolysis studies.

Indexed as

ErythrocytesHemolysisHumansantimicrobial peptides (AMPs)cytotoxicityhemolysis assayhemolysis ratio

Identifiers

PMID36769243
PMCPMC9917735

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.